Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,196.01
(
2.77%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
94.92
(
-6.22%
)
Bitcoin
71,639.70
(
-0.48%
)
News Focus
News Focus
Post# of 444922
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

tangerine

Send PM Follow Ignore
Followers 51
Posts 6706
Boards Moderated 0
Alias Born 01/17/2011

tangerine

Re: dr_lowenstein post# 54803

Tuesday, 05/07/2013 4:31:27 PM

Tuesday, May 07, 2013 4:31:27 PM

Post# of 444922
Glad you note it is incredibly undervalued which we all know. Are you still claiming we are headed into PH3 for a once a day Oxycontin or just the studies required for ANDA and 505B2 submissions? I believe the once a day Oxycontin will come later but it could happen.

Perhaps that is why Actavis is partnered with Elite on a 505B2 product through Mikah? Or do you think that product is a different abuse resistant opioid?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ELTP News
More ELTP News